EN
AM RU

FDA Laboratory

You can live healthy!

Audit Conducted in Drug Quality Control and Bioequivalence Studies Department in Accordance with International GLP/GCLP Standards

In the Department of Drug Quality Control and Bioequivalence Studies, we continue conducting bio-sample tests.

During these tests, an appropriate method has already been developed, validated and an audit has been conducted.

The audit was carried out in accordance with GLP/GCLP (Good Laboratory Practice/Good Clinical Laboratory Practice) principles, during which the expert assessed compliance of the studies with these principles and quality management requirements.

The audit was conducted by Maria Zaytseva, a leading expert in the field of preclinical and clinical research, GLP system specialist, member of the British Association for Quality in Scientific and Clinical Research, and Candidate of Medical Sciences.

Good results were recorded during the audit, demonstrating that the course and results of the studies are reliable and meet international standards․

 






Laboratory
Complex 2012
"FDA Laboratory"LLC

International
Accreditation
2015 ANAB